SCHEMBL22911966

SCHEMBL22911966

Nc1ncc(C#CSI)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22911956 0.77 — —
SCHEMBL23627445 0.74 NOS3 (0.30) —
SCHEMBL22911964 0.71 HDAC1 (0.31) —
SCHEMBL18714259 0.69 DRD2 (0.34) —
SCHEMBL26178491 0.65 — —
SCHEMBL24078827 0.63 SIRT6 (0.36) —
SCHEMBL21536602 0.61 GRM5 (0.46) —
SCHEMBL20935616 0.61 KDM4E (0.33) —
SCHEMBL21536559 0.61 ADRA2A (0.32) —
SCHEMBL24436467 0.60 NNMT (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388990-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES KINNATE BIOPHARMA INC. 2022-12-08 — — US disclosed
WO-2021011796-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES KINNATE BIOPHARMA INC. (US) 2021-01-21 — — WO disclosed
Send feedback